当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第34期 > 正文
编号:13071046
紫铆因改善化疗损伤卵巢功能的研究(5)
http://www.100md.com 2016年12月5日 中国现代医生2016年第34期
     [13] Blumenfeld Z. Endocrine prevention of chemotherapy-induced ovarian failure[J]. Future Oncology,2016,12(14):1671-1674.

    [14] Schmidt KT,Rosendahl M,Ernst E,et al. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure:The Danish experience[J]. Fertility & Sterility,2011,95(2):695-701.

    [15] Zhang L, Yang X, Li XU,et al. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a[J]. International Journal of Molecular Medicine,2015,36(4):957-966.

    [16] Seo WY,Youn GS,Choi SY,et al. Butein,a tetrahydroxychalcone,suppresses pro-inflammatory responses in HaCaT keratinocytes[J]. Bmb Reports,2015,48(9):495-500.

    [17] 徐安然,鄧晓惠. 放化疗致卵巢损害的机制及其组织学改变[J]. 国际生殖健康/计划生育杂志,2006,25(6):333-336.

    [18] Qin JJ,Rui-Man LI,Qian WU. Effects of different prescriptions for reinforcing kidney on chemotherapy-induced premature ovarian failure[J]. Chinese Journal of Pathophysiology, 2012,28(10):1847-1850.

    [19] Falcone T,Moore HC. GnRH agonist for gonadal protection during chemotherapy[J]. Human Reproduction,2015, 30(12):2711-2712.

    [20] Laura Bordone,Cohen D,Ashley Robinson,et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction[J]. Aging Cell,2007,6(6):759-767.

    (收稿日期:2016-09-16) (张琼 梁宗文 张安琪 卢晓声 朱望爱 胡越)
上一页1 2 3 4 5